Dispensing device and pharmaceutical composition for the treatment of rhinitis

US12303635B2 · kind B2 · utility

Assignee

• GLENMARK SPECIALTY S.A. · CH

Inventors

• Ulhas R. Dhuppad · Jamkhed, IN
• Ashok Katkurwar · Ashti, IN
• Yashwant Gupta · Jamkhed, IN
• Rajesh Ankam · Jamkhed, IN
• Chandrakant Dhatrak · Jamkhed, IN
• Neelima Khairatkar-Joshi · Thane, IN
• Abhay Kulkarni · Navi Mumbai, IN
• Dinesh Pradeep Wale · Osmanabad, IN
• Vikram M. Bhosale · Mumbai, IN
• Piyush Agarwal · Mumbai, IN
• Patrick Keohane · London, GB
• Sudeesh K. Tantry · Jamison, US
• Chad Oh · San Francisco, US

Key dates

• Filing date: May 1, 2023
• Grant date: May 20, 2025
• Expiry date: Feb 9, 2044

Classification

• Technology area (CPC B): Performing Operations; Transporting
• CPC primary: B05B11/0037
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A nasal dispensing device and pharmaceutical composition includes a container; a dispenser head having at least a pump, a dispensing channel, and a dispensing orifice; a dip tube; and a pharmaceutical composition comprising mometasone, an ester thereof (e.g., mometasone furoate), or a salt thereof and olopatadine or its salt (e.g., olopatadine hydrochloride). The container can have a conically shaped internal bottom, angled downwardly toward a center, and a further angularly deepened well, centrally located, with the dip tube extending into the well. An optional cap is provided that includes a sealing sleeve communicating in a seal tight manner with a perimeter of a lateral wall of the dispenser head.